Each year, the selection of strains to be included in the influenza vaccine is based on information about influenza virus circulating worldwide during the previous season and on recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee.
What does VRBPAC stand for?
VRBPAC stands for Vaccines and Related Biological Products Advisory Committee
This definition appears very frequently and is found in the following Acronym Finder categories:
- Military and Government
- Science, medicine, engineering, etc.
- Virtual Reality Battery Command Post
- Violet Red Bile Dextrose Agar
- Voter Registration/Ballot Delivery
- Volumetric Rate of the Blood Flow
- Violet Red Bile Glucose (agar)
- Virtual Reality Baseball League
- Virtual Reality Behavior Language
- Vancouver Romanian Business Network (New Westminster, BC)
- Vacation Rentals by Owner
- Virtual Reality Behavior System
- Video Ring Back Tone
- Virtual Reality-Based Technology (dentistry)
- Virtual Remote Batch Terminal (computing)
- Fleet Logistics Support Squadron (US Navy designation for naval aviation transport unit)
- Fleet Tactical Support Squadron (US Navy aviation unit designation used from 1960 to 1976)
- Vaccine Research Center (National Institutes of Health)
- Validation Review Committee
- Vallespir Rétro Course (French car club)
- Valley Resource Center (California)
Samples in periodicals archive:
The Vaccines and Related Biological Products Advisory Committee members voted to accept the choices recommended by the World Health Organization for next year's trivalent vaccine: an A/Brisbane/59/2007 (HlNl)-like virus, an A/Brisbane/10/2007 (H3N2)-like virus, and a B/ Florida/4/2006-like virus.
The Vaccines and Related Biological Products Advisory Committee followed the lead of the World Health Organization, which made its recommendations for a Northern Hemisphere winter vaccine a week earlier.
The influenza vaccine to be given in the 2002-2003 flu season should be changed to include a component against the B/Hong Kong/330/2001-like virus, the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee has recommended.